Technology platform
————
Sunmao Medical has a rare integrated technology platform for innovative nuclear medicine process research and nuclear medicine equipment development in the world. Sunmao focuses on the development of original nuclear medicine automation and intelligent equipment, and is committed to the whole process automation of all business links in the nuclear medicine industry chain.
Nuclear medicine equipment r&d technology platform with a total area of about 1000 square meters, containing radioactive chemistry laboratory and automation technology central laboratory , equipped with various advanced equipment, satisfy the basic research of nuclear medicine technology, intelligent and automation equipment research and development needs. The research platform based on equipment research and development and the new technology of double experience (core competencies), nuclear medicine technology research team have developed: nuclide purification, small molecule compounds, peptides, antibodies macromolecular markers such as mature technology. The automation technology team can convert the aforementioned process technology into automated equipment, continuously achieve technological breakthroughs in high-end machinery, and ultimately accomplish mass production and market penetration.
Sunmao Medical boasts a globally rare, integrated technology platform for innovative radiopharmaceutical process development and nuclear medicine equipment development. The company specializes in the development of original radiopharmaceutical automated intelligent equipment, dedicated to full-process automation across the entire nuclear medicine industry chain, including upstream, midstream, and downstream business segments.
The nuclear medicine equipment research and development technology platform covers a total area of approximately 1,000 square meters. It includes a radiochemistry laboratory and an automation technology center laboratory, equipped with various advanced devices to meet the needs of foundational research in nuclear medicine processes as well as the development of automated intelligent equipment.
Leveraging dual expertise in equipment development and foundational research of new drug processes (core competencies), the nuclear medicine foundational process research team has developed mature technologies in radionuclide separation and purification, small molecule compounds, peptide compounds, and antibody macromolecule labeling. The automation technology team transforms these process technologies into automated equipment, continuously achieving technological breakthroughs in high-end equipment, ultimately enabling mass production and market release of the products.
86-0510-88786189
